Bayer - 15 Year Stock Price History | BAYRY
Historical daily share price chart and data for Bayer since 2011 adjusted for splits and dividends. The latest closing stock price for Bayer as of September 03, 2026 is 14.35.
- The all-time high Bayer stock closing price was 27.55 on July 14, 2015.
- The Bayer 52-week high stock price is 15.23, which is 6.1% above the current share price.
- The Bayer 52-week low stock price is 7.48, which is 47.9% below the current share price.
- The average Bayer stock price for the last 52 weeks is 11.13.
| Bayer Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 12.2810 | 11.0568 | 15.1850 | 9.8800 | 14.3450 | 32.98% |
| 2025 | 7.3602 | 4.9020 | 10.7876 | 4.8176 | 10.7876 | 122.77% |
| 2024 | 7.2054 | 9.2700 | 9.6357 | 4.8127 | 4.8424 | -46.91% |
| 2023 | 13.1843 | 12.3715 | 16.0725 | 8.2323 | 9.1218 | -25.35% |
| 2022 | 13.7679 | 12.3611 | 17.0084 | 10.8987 | 12.2195 | 0.35% |
| 2021 | 13.6046 | 13.3279 | 15.9059 | 11.5162 | 12.1774 | -7.34% |
| 2020 | 14.4385 | 17.5468 | 18.2659 | 10.3878 | 13.1419 | -23.40% |
| 2019 | 14.9183 | 14.0531 | 17.4977 | 12.4621 | 17.1576 | 20.91% |
| 2018 | 20.5512 | 23.7604 | 25.7130 | 13.7624 | 14.1904 | -40.16% |
| 2017 | 23.5961 | 19.8827 | 26.9182 | 19.8426 | 23.7145 | 22.11% |
| 2016 | 19.5520 | 21.8478 | 22.6846 | 17.1889 | 19.4199 | -14.48% |
| 2015 | 24.5619 | 22.5993 | 27.5544 | 21.6164 | 22.7092 | -0.04% |
| 2014 | 22.6374 | 22.1801 | 24.9552 | 20.5984 | 22.7188 | -1.48% |
| 2013 | 18.0287 | 14.9826 | 23.1740 | 14.5706 | 23.0603 | 51.72% |
| 2012 | 11.9757 | 10.3058 | 15.2722 | 9.5189 | 15.1997 | 55.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Large Cap Pharmaceutical | $55.767B | $51.552B |
| Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eli Lilly (LLY) | United States | $1081.958B | 36.50 |
| Johnson & Johnson (JNJ) | United States | $663.276B | 25.34 |
| AbbVie (ABBV) | United States | $453.112B | 23.59 |
| Merck (MRK) | United States | $370.890B | 46.83 |
| Roche Holding AG (RHHBY) | Switzerland | $350.157B | 0.00 |
| Novartis AG (NVS) | Switzerland | $305.285B | 18.43 |
| Novo Nordisk (NVO) | Denmark | $208.069B | 11.59 |
| Pfizer (PFE) | United States | $162.156B | 9.33 |
| Sanofi (SNY) | France | $107.257B | 9.03 |
| Innoviva (INVA) | United States | $1.541B | 5.27 |